if that UPPP adversely influences the future use of continuous positive airway pressure (CPAP).
The first worry (a) we agree concerning the difficulties when evaluating a twostage treatment. However, the aim of SKUP 3 was to evaluate the effect of UPPP, which includes tonsillectomy per definition and has been a well-known surgical treatment for obstructive sleep apnoea syndrome (OSAS) since it was first introduced in 1981. 2 Stradling and Kohler refer to a study of nine OSAS patients with large tonsils who underwent tonsillectomy with an 80% success rate, similar to that in children. Adult OSAS patients with large tonsils are few in number, only 6% according to one study. 3 The majority have a soft palate and uvula that has been traumatised and deranged after several years of snoring and vibrations, leading to bulky tissue, which obstructs the airway during sleep. The results from our previous study of 158 OSAS patients undergoing UPPP showed that tonsil size was not a success factor. 4 In our experience, tonsillectomy is important as a part of UPPP in OSAS also in patients with small tonsils, as it enables the lateralisation and suturing of the posterior tonsillar pillar, thus widening the airway space, and our studies support this view.
Furthermore, a meta-analysis of UPP showed an apnoea-hypopnoea index reduction of 32%, comparable with 33% in UPPP, 5 indicating that the palatal operation also improves nocturnal respiration. However, randomised controlled trials comparing tonsillectomy, UPP and UPPP are recommended to further clarify this question.
The second worry of Stradling and Kohler concerns (b) whether UPPP influences future use of CPAP, referring to a study from 1996. The surgical method used at the start in the 1980s and 90s was more radical than it is today. We are performing only minor resections of the soft palate and uvula, that is, a modified UPPP. There is a scarcity of reports on this issue. However, a small Chinese study compared the classical UPPP with a modified UPPP and noted that all the problems with CPAP titrations occurred in the group of classical UPPP patients. 6 Further prospective studies are also needed in this matter. British Thoracic Society guideline on pulmonary rehabilitation in adults: does objectivity have a sliding scale?
We congratulate the Guideline Development Group (GDG) on the publication of their new pulmonary rehabilitation guideline. 1 However, we are concerned by the contrasting recommendations for limb resistance training (LRT), which is recommended, and for inspiratory muscle training (IMT), which is not. Both interventions have identical levels of evidence (1+) and similar evidence statements.
The evidence statement in relation to LRT is as follows:
In patients with COPD, resistance training in combination with aerobic training does not lead to additional benefits to health-related quality of life, dyspnoea or exercise tolerance compared with aerobic training alone. (Evidence level 1+)
The GDG puts forward a number of arguments to justify recommending LRT, despite the evidence level being 1+: ▸ Lower limb weakness is common in COPD and is a poor prognostic indicator. ▸ LRT has other benefits, such as reducing falls in older people in general. ▸ LRT in combination with aerobic training results in greater improvements in peripheral muscle strength than aerobic training alone. The claim that LRT reduces falls in older people is not supported by a citation, and our understanding is that this link remains equivocal. The other mitigating claims are not unique to LRT (see below).
The evidence statement relating to IMT is very similar to the statement for LRT, but the resulting recommendation is entirely different:
IMT using threshold loading devices or normocapnoeic hyperpnoea does not appear to augment the beneficial effects of general exercise training in patients with COPD. (Evidence level 1+)
IMT is not recommended as a routine adjunct to pulmonary rehabilitation.
To our eyes, based upon the evidence statements, the differing recommendations are inconsistent, particularly as the mitigating factors used by the GDG to justify its recommendation of LRT also hold true for IMT: ▸ Inspiratory muscle weakness is also common in COPD and is an independent determinant of survival.
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▸ IMT in combination with exercise training yields larger improvements in inspiratory muscles strength and endurance than aerobic training alone. 3 Perhaps most importantly, unlike LRT, standalone IMT is an evidence-based intervention in its own right, and is supported by systematic reviews and meta-analyses. 3 4 Established benefits include, "inspiratory muscle strength and endurance, functional exercise capacity, dyspnoea and quality of life".
The British Thoracic Society guideline on pulmonary rehabilitation in adults: your opinion is noted
We thank Professors McConnell and Gosselink for their interest in the British Thoracic Society (BTS) pulmonary rehabilitation guideline. 1 2 We welcome the opportunity to highlight the robust, unbiased approach that the guideline development group (GDG) has followed in making their recommendations which have been accredited by National Institute of Health and Care Excellence. This process, according to the BTS production manual, is described in the guideline methodology. 2 It included initial training, each article being considered by at least two GDG members, independent peer review at multiple stages and consultation periods for the public and stakeholders. Continuously updated declaration of interest forms were submitted.
The correspondents question why inspiratory muscle training (IMT) is not recommended as a routine adjunct to pulmonary rehabilitation. The guideline discusses the background to IMT and the nature of the trials undertaken, including a considered judgement of the risk of bias therein. The randomised controlled trials (RCTs) at lowest risk of bias found IMT was of no benefit as an adjunct to the primary aims of rehabilitation, and hence it was not routinely recommended. A similar statement has been adopted in the recent American Thoracic Society/ European Respiratory Society statement on pulmonary rehabilitation. 3 The label of '1+' is a standard assessment of the evidence level informing the recommendation, not of the strength of support for using the named intervention. As the trials included exercise rather than multidisciplinary pulmonary rehabilitation, the recommendation was at Grade B. A high-quality RCT of high-intensity IMT in parallel to pulmonary rehabilitation focusing on functional exercise capacity and health status is required. As we state, consideration of individual interventions such as role of oxygen or IMT in isolation was beyond the remit of the guideline. The recommendation that limb resistance training is used in addition to aerobic training to improve muscle strength follows from this and has been contextualised in this manner and approved by subsequent reviewers. The recommendation is extrapolated from exercise-based RCTs with a low risk of bias (ie, Grade B). 2 In the relevant sections, reference to the importance of peripheral muscle strength regarding mortality and healthcare utilisation is made, including one publication by Professor Gosselink. The guideline correctly states that other benefits are beyond the scope of the document.
We hope that high-quality, unbiased research in pulmonary rehabilitation continues to accrue and thus guide future iterations of the BTS pulmonary rehabilitation guideline.
